MORE, www.pausetheworldforpeace.org

Vigil and Press Conference

to denounce last night’s murder

of two Israeli embassy

employees in Washington D.C.

We also share some of our important content from Earth Day and Health and Wellness interviews that we do on Good News. 

Here is Good News for EARTH DAY 2025: Go to www.pausetheworldforpeace.org to watch the entire broadcast.

Earth Day 2025 Recap

1.5 Million Views

Earth Day Sizzle Reel

from Times Square

April 22, 2025

EARTH DAY TIMES SQUARE

2025 FEATURED ON THE PRIME

TIME MNN NEW YORK

BROADCAST. Will air on MNN ON

5/28/2025 at 9pm est.

Here is Health and Wellness from our 7,000+ Shows on www.goodnewsplanet.TV and www.youtube.com/goodnewsbroadcast, established on July 4, 1998…WOW!

Rare Liver Disease

– biliary cholangitis

A diagnosis of

chronic

lymphocytic (LIM-foh-SIH-tik)

leukemia (C-L-L)

can be overwhelming,

but advances in cancer

research…

Please donate here and possibly win a trip to the Montauk Manor:   https://goodnewsplanet.com/pausetheworld/peace-day-donations/

IT’S NOT TOO LATE TO BE INVOLVED BY SPONSORING, DONATING, AND VOLUNTEERING FOR THE INTERNATIONAL DAY OF PEACE WEEKEND EVENTS AND CONCERT IN TIMES SQUARE ON SEPTEMBER 19, 20, 21, 2025… CALL 212 647 1212 or email me paul.sladkus1@gmail.com

Lastly, if you care about your money, please tune in to WOR 710 Radio on Sunday at 10:30 AM. Here you can listen and call in to Legal Expert and Elder Care Lawyer, 14 Year NYS Representative and Dr. Phil, ET, Good Morning America…Guest Lawyer, Ann-Margaret Carrozza, ESQ. 

Ann is BRILLIANT, AND YOUR MONEY IS BRILLIANT, AND YOU ARE BRILLIANT IF YOU ARE SMART ENOUGH TO PROTECT IT.

Paul Sladkus is Ann’s Co-Host. Email me paul.sladkus1@gmail.com if you want me to ask her a question, or just call in (800-321-0710) and listen; it might be one of the most important programs in you and your family’s life.

Ann-Margaret Carrozza,

Asset Protection Lawyer,

WOR 710 AM

CALL IN Radio

LIVE Every

Sunday at 1030am

STAY WELL

Please support our nonprofit, 501 C 3, Good News Corporation at http://goodnewsplanet.com/peacedayparty/peace-day-donations/

LET’S GROW TOGETHER. GOOD NEWS MOTTO: “All we are is what we are with each other.” Zeal 

With Respect. Love and May Peace Prevail on Earth,  For Information Contact: 

Reverend Paul Sladkus, All Faiths and Spiritual,

Founder, Good News Corporation 501 C 3 212 647 1212 paul.sladkus1@gmail.com  and our Good News and Peace Worldwide Team who make our Peace Day 9/21 happen.

www.pausetheworldforpeace.org,www.goodnewsplanet.TV, www.youtube.com/goodnewsbroadcast

Social Networks: www.Facebook.com/PaulSladkus, LinkedIn Paul Sladkus, Twitter/X Good News to Go, Instagram PausetheWorld

LET’S GROW TOGETHER. GOOD NEWS MOTTO: ALL WE ARE IS WHAT WE ARE WITH EACH OTHER. ZEAL

For more information contact: 

Reverend Paul Sladkus, All Faiths and Spiritual 212 647 1212

New York, NY, Montauk, NY

PS – SPECIAL OPPORTUNITY FOR OUR FRIENDS AND MEMBERS: Looking for a vacation rental, SHORT TERM, in Montauk, this year and or entire summer in 2026, here is our listing https://pausetheworldforpeace.org/2025/04/16/36000-2br-one-of-a-kind-summer-rental-opportunty-historic-montauk-manor-montauk/  call me. Paul 917 687 1790

The post GoodNewsLetter: PEACE CONCERNS – Earth Day 2025 had 1.5 Million Viewers & GROWING – Details, MNN Earth Day Prime Time Broadcast 5/28, Health and Wellness Content… appeared first on Good News!.

A diagnosis of chronic lymphocytic (LIM-foh-SIH-tik) leukemia (C-L-L) can be overwhelming, but advances in cancer research, including targeted therapies, have paved the way for more precise treatments. C-L-L is one of the most common blood cancers in adults, and because its progression varies from person to person, choosing a tailored treatment plan is crucial.

brukinsa.com

Today, we’re joined by Lynne who will share her personal journey with C-L-L, and Dr. Nakhle Saba [Knack-Leigh Sah-bah], director of lymphoid malignancy and CAR T-cell (Car-tee cell )therapy at Our Lady of the Lake Cancer Institute, who will provide insight into the latest treatment approaches and why informed decision-making is so essential for those facing this disease.

BIO’s

Dr. Saba

Dr. Saba earned his medical degree from the Lebanese University in Beirut 2005. He completed his residency in Internal Medicine at East Tennessee State University in Johnson City, TN and Tulane University in New Orleans, LA, and his fellowship in Hematology and Medical Oncology at Tulane University. After fellowship completion in 2011, Dr. Saba joined the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH) for an additional fellowship in lymphoid malignancies. His research at the NIH was focused on tumor biology and developing new therapeutic approaches for leukemia and lymphoma. He returned to Tulane in 2014 as Assistant Professor of Medicine, promoted to Associate Professor in 2018, then to Professor in 2024 following a successful career in research, teaching, and treating blood cancers. Dr. Saba’s research focuses on lymphoid malignancies and cell therapy, to identify therapeutic targets and novel drugs for these diseases.

Dr. Saba’s leadership skills are evident by the roles he played at Tulane as chair of the “immune effector cell therapy – IECT”, co-chair of Sarah-Cannon Lymphoma Committee, and President of Louisiana Oncology Society (LOS). Under his direction as president, the LOS passed four bills that were signed into law in Louisiana and are expected to positively impact cancer care in our state. Those bills include the Bone Marrow Donation, Fertility Preservation For Cancer Patients, Right To Prompt Coverage, and Expansion Of Biomarker Testing.

Dr. Saba authored and/or co-authored more than 120 published manuscripts and research abstracts, he presented at regional, national, and international meetings as a researcher and invited speaker. His articles appear in journals like Blood, Leukemia, Cancer Research, The Lancet Haematology, Haematologica, Science Advances, Bone Marrow Transplant and others. Click to access  Dr. Saba’s Bibliography on PubMed  or Dr. Saba’s Articles, Abstracts, and Citations

Dr. Saba was recruited at the Our Lady of the Lake Cancer Institute as Professor of Medicine at LSU Health Sciences Center, and Director of Lymphoma, CLL, and chimeric antigen receptor (CAR)-T. He will be diligently working to expand the lymphoma and CLL research portfolio and bring cutting edge therapies to the region such as CAR-T, the next generation CARs, and be the first to bring the tumor infiltrating lymphocytes (TILs) for solid tumors to Louisiana.

About Lynne

I am a very active, “young” senior citizen whose priorities are my grown children and their partners, my 3-year-old grandson, 20-month-old granddaughter, and my longtime partner. I have a huge passion for all animals, and love doing Pilates, aerobics, Zumba Gold, and weight training. I became a pescetarian about 10 years ago. I was diagnosed with a very specific high-risk subtype of Chronic Lymphocytic Leukemia (CLL) in April 2019, three weeks after the tragic passing of my third child, my 26-year-old daughter. I was so devastated by her death, and now facing an unknown diagnosis, I turned to the Leukemia & Lymphoma Society (LLS) for support. Fast-forwarding to now, I have been on the “Light The Night” Executive Leadership Committee for the Westchester/Fairfield LLS for four years, and my team “Lynne’s Hope” has raised almost $200,000 for the cause, for which I am extremely proud. I am blessed to be under the care of a world-renowned CLL specialist. I want cancer survivors to know there is hope for us to live a long life because of all the constant new medical treatments that are being discovered every day. I have been in treatment for two years for CLL and am doing great! My mantra is, “I will not let Leukemia define me; I will define it!”

The post A diagnosis of chronic lymphocytic (LIM-foh-SIH-tik) leukemia (C-L-L) can be overwhelming, but advances in cancer research… appeared first on Good News!.